Volume 34, No 1, Jan 2024

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 34 Issue 1, January 2024: 11-12

RESEARCH HIGHLIGHTS

LICOB: a powerful organoid platform for drug discovery

Haojie Jin^1,2,†,* , Zhen Sun^1,† , René Bernards^1,2,*

¹State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
²Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. 3 These authors contributed equally: Haojie Jin, Zhen Sun
^†These authors contributed equally: Haojie Jin, Zhen Sun
Correspondence: Haojie Jin(hjjin1986@126.com)René Bernards(r.bernards@nki.nl)

A comprehensive patient-derived organoid biobank was established, which recapitulates the histological and molecular features of primary liver cancer, enabling drug discovery.

https://doi.org/10.1038/s41422-023-00878-0

FULL TEXT | PDF

Browse 198